A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Cardiac Safe Transplants for Systemic Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CD19-Specific T Cells Post AlloSCT
- Status
- TERMINATED
- Phase
- PHASE1
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
- Status
- COMPLETED
- Phase
- PHASE1
BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE1
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
TIL-ACT After NMA Chemo with IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL)
- Status
- COMPLETED
- Phase
- PHASE1
CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1